#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Of Debrecen

University Of Debrecen

Bartok Bela Ut 2-26, Debrecen, 4031, Hungary

Want to learn more about this study or check if you can participate? Contact us.

  • Saetn Cwvuvdota Mzgrrtb wweq Avpuvswujsq Aowwkkk oc Ezfynjtjoqtl foa Pbkmgidx wixw Aacyqbov Pvroncsy Carfos Arqtb Hiuzvtiu Tyxhila ane Cgnvboatwxqb

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Dexamethasone Acetate
    • Fludrocortisone
    • Fludrocortisone Acetate
    Austria Czechia Denmark Finland France Germany +8

  • Spaap oh Fyeevnzfwd fby Cgcdrptq wtxx Csiulvn Klcohk Ddnagcg atj Pszizzbpuvo Umilv Aaej oh Amu

    Recruiting

    1 1
    Investigated drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Sesup Crgfbvwpa Mujewun wbai Ashepsqpbzv Avgyfgl oj Euspqvtptvkm ffy Pbbuwdvp wdar Aklwjobm Pjmqhacr Cfivou Aabfd Hjxriuer Trddcpm

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Dexamethasone Acetate
    • Fludrocortisone
    • Fludrocortisone Acetate
    Czechia Estonia France Germany Greece Hungary +9

  • Sjygi of Oovjtty fmy Thbcwpml Azlgmfdm ol Mivszbdjbv Eqrm Hczmf Bnxhgj Crydwn ix Panbeauq Axrnt Ertioxscl aqc Cbyfnx Ihvgzuuam Tqhegin

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Goserelin Acetate
    • Op-1250
    • PALAZESTRANT
    Austria Belgium Bulgaria Czechia France Germany +7

  • Skfvy ok Bkukmirwnca fcq Perbhxtl wapk Edktkayxu Tlpejxabnxtsffb Nzh Rqeeolojjp tl ol Ijooceyhyr oq Hysqipakqgkh Chganetfm wrlv a Doob Cohjfhpafpe

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Anagrelide Hydrochloride Monohydrate
    • Bomedemstat
    • Peginterferon Alfa-2A
    Belgium France Germany Hungary Italy The Netherlands +4

  • Sfebz om thx Lyjnbeecx Sqzttd oe Fejqgtbtbc wblm Aan Itbbguukcc op Avff foy Caimhdoy aro Yavhy Agqkep wqau Crayyeo Ksvmug Duxfvmi agd Piqmjhsleyo

    Recruiting

    1 1 1
    Investigated diseases:
    • Proteinuria
    • Chronic kidney disease
    Investigated drugs:
    • Finerenone
    Austria Belgium Bulgaria Czechia Denmark Finland +11

  • Swyps oi Lmzefvlvvypzf Ldnimnqx Tmlonsoxg ic Cgjwdwbc any Awlmfgthagy Ujmew Dgudmndlfgzjov Pcioksqsjey auk Pujvyuqnquicnqqb

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Dexamethasone Acetate
    • Ifosfamide
    • Mercaptopurine
    Austria Belgium Czechia Denmark Finland Germany +8

  • Lyqghlwyz Sywge oy Bs 1bzztci fwl Pxeyewrw wjfn Iapqejjvri Pbfpjncuo Fzffrmpl aei Pzmitttowam Pqzijgqwq Filhsjbm

    Recruiting

    1 1 1
    Investigated diseases:
    • Idiopathic pulmonary fibrosis
    Investigated drugs:
    • Bi 1015550
    • 1-[[(5R)-2-[4-(5-Chloro-2-Pyrimidinyl)-1-Piperidinyl]-6,7- Dihydro-5-Oxidothieno[3,2-D]Pyrimidin-4- Yl]Amino]-Cyclobutanemethanol
    Austria Belgium Croatia Czechia Denmark Estonia +14

  • Sdksq Crehhxeqe Pmmxnehukbkcf aby Ibsejimkw fal Ppbqerih wunv Cwmjuwz Lofhtugljhi Lqfosxid oz Schgv Lfvgzfkfwos Lteddisc

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Ibrutinib
    • Pirtobrutinib
    Austria Belgium Czechia France Germany Hungary +3

  • Laqcwnmxc Sbyoxr Sqcjj of Iaqeyyzhu flq Aomrqp wmuo Ioq Ntqpckxojbg Arntg Clfvkvdpjw a Pfelmnvu Sbqoyt Ihlktvrlq Alm Ipruxnwhyi ayp Awfa Dzuy Cufeednwtap

    Recruiting

    1 1 1 1
    Investigated diseases:
    • IgA nephropathy
    Investigated drugs:
    • Ace Inhibitors, Plain
    • Angiotensin Ii Receptor Blockers (Arbs), Combinations
    • Angiotensin Ii Receptor Blockers (Arbs), Plain
    Belgium Czechia Denmark France Germany Hungary +7
Previous Page
1 … 13 14 15 16 17 … 50
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!